Evaluation of a Spasticity Management Program for People With Multiple Sclerosis

Conditions

• Multiple Sclerosis

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Spasticity Take Control — BEHAVIORAL
  Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and a stretching program for spasticity management.
• Stretching for People with MS: An Illustrated Manual — BEHAVIORAL
  Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and exercises for spasticity management from the manual.

Study Details

This study will examine the impacts of two different methods of managing MS-related spasticity of the lower limbs. Both interventions will be presented via video teleconference in group classes consisting of exercises to reduce spasticity.

Key Dates

Start date

Jan 1, 2018

Status verified

Mar 2026

Primary completion

Jul 30, 2021

Completion

Jan 31, 2022

Study Design

Enrollment

232 participants (actual)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Spasticity Take Control
  Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and a stretching program for spasticity management.
• Active Comparator: Stretching for People with MS: An Illustrated Manual
  Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and exercises for spasticity management.

Primary Outcome Measure

Impact of Spasticity, Measured by the Multiple Sclerosis Spasticity Scale-88 [ Time Frame: One month post-intervention ]

Locations (1)

Find similar trials in Portland, OR

Related Studies

• A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
  PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama
• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  Recruiting · TG Therapeutics, Inc. · Birmingham, Alabama
• Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
  Recruiting · Accelerated Cure Project for Multiple Sclerosis · Washington D.C., District of Columbia
• Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
  Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland